W.K. Kroeze, S.J. Hufeisen, B.A. Popadak, S.M. Renock i inni. H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. „Neuropsychopharmacology”. 28 (3), s. 519–526, Mar 2003. DOI: 10.1038/sj.npp.1300027. PMID: 12629531.
P. Seeman, R. Corbett, H.H. Van Tol. Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors. „Neuropsychopharmacology”. 16 (2), s. 93-110; discussion 111–135, 1997. DOI: 10.1016/S0893-133X(96)00187-X. PMID: 9015795.
E.S. Burstein, J. Ma, S. Wong, Y. Gao i inni. Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist. „Journal of Pharmacology and Experimental Therapeutics”. 315 (3), s. 1278–1287, 2005. DOI: 10.1124/jpet.105.092155. PMID: 16135699.
W.K. Kroeze, S.J. Hufeisen, B.A. Popadak, S.M. Renock i inni. H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. „Neuropsychopharmacology”. 28 (3), s. 519–526, Mar 2003. DOI: 10.1038/sj.npp.1300027. PMID: 12629531.
P. Seeman, R. Corbett, H.H. Van Tol. Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors. „Neuropsychopharmacology”. 16 (2), s. 93-110; discussion 111–135, 1997. DOI: 10.1016/S0893-133X(96)00187-X. PMID: 9015795.
E.S. Burstein, J. Ma, S. Wong, Y. Gao i inni. Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist. „Journal of Pharmacology and Experimental Therapeutics”. 315 (3), s. 1278–1287, 2005. DOI: 10.1124/jpet.105.092155. PMID: 16135699.
E. Richelson. Neuroleptic binding to human brain receptors: relation to clinical effects. „Annals of the New York Academy of Sciences”. 537, s. 435–442, 1988. PMID: 2904784.